Michael Hale

1.3k total citations
18 papers, 650 citations indexed

About

Michael Hale is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Michael Hale has authored 18 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Michael Hale's work include Antibiotic Resistance in Bacteria (4 papers), HIV Research and Treatment (3 papers) and Synthetic Organic Chemistry Methods (3 papers). Michael Hale is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), HIV Research and Treatment (3 papers) and Synthetic Organic Chemistry Methods (3 papers). Michael Hale collaborates with scholars based in United States, United Kingdom and Spain. Michael Hale's co-authors include Amir H. Hoveyda, Gregory S. Bisacchi, Christopher Baker, Kilian W. Conde‐Frieboes, Harry H. Wasserman, Andrew Spaltenstein, Edward A. Dennis, Roger D. Tung, Laure J. Reynolds and Eric S. Furfine and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and The FASEB Journal.

In The Last Decade

Michael Hale

17 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hale United States 13 329 240 148 75 75 18 650
Jay A. Markwalder United States 13 467 1.4× 285 1.2× 146 1.0× 69 0.9× 32 0.4× 18 897
Fisayo A. Olotu South Africa 18 439 1.3× 160 0.7× 144 1.0× 31 0.4× 162 2.2× 79 857
David D. Anderson United States 16 266 0.8× 320 1.3× 183 1.2× 149 2.0× 53 0.7× 26 771
Ya-Qiu Long United States 19 407 1.2× 388 1.6× 188 1.3× 149 2.0× 33 0.4× 23 818
Lianhong Xu United States 18 270 0.8× 378 1.6× 231 1.6× 146 1.9× 51 0.7× 42 920
Olaf Kinzel Italy 17 389 1.2× 255 1.1× 122 0.8× 72 1.0× 45 0.6× 42 964
Steven Hansel United States 14 200 0.6× 109 0.5× 72 0.5× 42 0.6× 91 1.2× 29 683
Sarah Barelier France 12 384 1.2× 85 0.4× 45 0.3× 32 0.4× 162 2.2× 17 552
Federico Falchi Italy 21 669 2.0× 302 1.3× 74 0.5× 67 0.9× 146 1.9× 47 1.2k
Keith Riccardi United States 17 349 1.1× 225 0.9× 194 1.3× 145 1.9× 112 1.5× 32 949

Countries citing papers authored by Michael Hale

Since Specialization
Citations

This map shows the geographic impact of Michael Hale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hale more than expected).

Fields of papers citing papers by Michael Hale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hale. The network helps show where Michael Hale may publish in the future.

Co-authorship network of co-authors of Michael Hale

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hale. A scholar is included among the top collaborators of Michael Hale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hale. Michael Hale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ryan, Meagan B., Bradley Quade, Natasha Schenk, et al.. (2024). The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers. Cancer Discovery. 14(7). 1190–1205. 16 indexed citations
2.
Soste, Martin, Maria Stella Ritorto, Klaus P. Hoeflich, et al.. (2024). Abstract 5776: Target identification, selectivity profiling and binding site mapping of small molecule and peptide drugs by LiP-MS. Cancer Research. 84(6_Supplement). 5776–5776.
3.
Rich, Alexander, Yvonne Chan, Benjamin Birnbaum, et al.. (2024). Machine Learning ADME Models in Practice: Four Guidelines from a Successful Lead Optimization Case Study. ACS Medicinal Chemistry Letters. 15(8). 1169–1173. 2 indexed citations
4.
Bisacchi, Gregory S. & Michael Hale. (2016). A “Double-Edged” Scaffold: Antitumor Power within the Antibacterial Quinolone. Current Medicinal Chemistry. 23(6). 520–577. 39 indexed citations
5.
Murphy-Benenato, Kerry E., Lakshmaiah Gingipalli, P. Ann Boriack‐Sjodin, et al.. (2015). Negishi cross-coupling enabled synthesis of novel NAD+-dependent DNA ligase inhibitors and SAR development. Bioorganic & Medicinal Chemistry Letters. 25(22). 5172–5177. 9 indexed citations
6.
Walkup, Grant K., Philip L. Ross, Fereidoon Daryaee, et al.. (2015). Translating slow-binding inhibition kinetics into cellular and in vivo effects. Nature Chemical Biology. 11(6). 416–423. 116 indexed citations
7.
Gupta, Anshul, Natalie Keirstead, Harish Shankaran, et al.. (2015). Toxicokinetic Insights are Critical to Understanding Renal Toxicity of Novel Polymyxin Analog. The FASEB Journal. 29(S1). 1 indexed citations
8.
Gao, Ning, Sarah M. McLeod, Laurel Hajec, et al.. (2014). Overexpression of Pseudomonas aeruginosa LpxC with its inhibitors in an acrB-deficient Escherichia coli strain. Protein Expression and Purification. 104. 57–64. 6 indexed citations
9.
Murphy-Benenato, Kerry E., N.B. Olivier, Allison L. Choy, et al.. (2014). Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors. ACS Medicinal Chemistry Letters. 5(11). 1213–1218. 21 indexed citations
10.
Hale, Michael, Pamela Hill, Sushmita D. Lahiri, et al.. (2013). Exploring the UDP pocket of LpxC through amino acid analogs. Bioorganic & Medicinal Chemistry Letters. 23(8). 2362–2367. 20 indexed citations
11.
12.
Aronov, Alex M., Christopher Baker, Guy W. Bemis, et al.. (2007). Flipped Out:  Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors. Journal of Medicinal Chemistry. 50(6). 1280–1287. 98 indexed citations
13.
Miller, John F., C. Webster Andrews, Eric S. Furfine, et al.. (2006). Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385. Bioorganic & Medicinal Chemistry Letters. 16(7). 1788–1794. 70 indexed citations
14.
Furfine, Eric S., Christopher Baker, Michael Hale, et al.. (2004). Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir. Antimicrobial Agents and Chemotherapy. 48(3). 791–798. 73 indexed citations
15.
Conde‐Frieboes, Kilian W., et al.. (1996). Activated Ketones as Inhibitors of Intracellular Ca2+-Dependent and Ca2+-Independent Phospholipase A2. Journal of the American Chemical Society. 118(24). 5519–5525. 78 indexed citations
16.
Young, David G., Michael Hale, & Amir H. Hoveyda. (1996). Highly diastereoselective hydrosilation reactions. Spirocyclic siloxanes: Sources of Si-based Lewis acids. Tetrahedron Letters. 37(6). 827–830. 14 indexed citations
17.
Hale, Michael & Amir H. Hoveyda. (1994). Diastereoselective Heteroatom-Directed Conjugate Addition of Silylcuprate Reagents to Unsaturated Carbonyls. A Stereoselective Route to .beta.-Carbonyl Siloxanes1. The Journal of Organic Chemistry. 59(16). 4370–4374. 14 indexed citations
18.
Hale, Michael & Amir H. Hoveyda. (1992). Siloxanes: versatile templates for acyclic stereocontrol. Synthesis of the C27-C33 segment of rapamycin. The Journal of Organic Chemistry. 57(6). 1643–1645. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jay A. Markwalder Breakdown of academic impact, for papers by Fisayo A. Olotu Breakdown of academic impact, for papers by David D. Anderson Breakdown of academic impact, for papers by Ya-Qiu Long Breakdown of academic impact, for papers by Lianhong Xu Breakdown of academic impact, for papers by Olaf Kinzel Breakdown of academic impact, for papers by Steven Hansel Breakdown of academic impact, for papers by Sarah Barelier Breakdown of academic impact, for papers by Federico Falchi Breakdown of academic impact, for papers by Keith Riccardi
Rankless by CCL
2026